| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00276991 NCT00385424 NCT00505193 NCT00554060 Details | 2015-11-04 Interventional | 1/2 | 40 | Immunomodulatin… HIV Infections | Lack of funding prevented the recruitment of 1000 HIV Patients all over India - | |||
| NCT02461186 Details | 2015-11-03 Interventional | 2/3 | 0 | Artenimol Piperaquine Malaria Malaria, Falcip… Artemisinin-res… Uncomplicated F… | Change of the study site due to the current political climate in Myanmar. - | |||
| NCT01842594 Details | 2015-11-03 Interventional | 2 | 13 | Hydroxychloroqu… Sirolimus Sarcoma | Most patients completed only the primary objective (PET) and not went throught the secondary
outcome (efficacy phase) of 8wks period. - | |||
| NCT01583647 2012-001443-49 Details | 2015-11-03 Interventional | 1 | 10 | Niacin Niacinamide Nicotinic Acids Hypercholestero… Hyperlipoprotei… Heterozygous Fa… Hypercholestero… | In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a
significant increase in incidence of some types of non-fatal SAEs. - | |||
| NCT01095250 2009-014834-22 Details | 2015-11-03 Interventional | 3 | 30 | Antibodies, Mon… Uveitis | Terminated: Study in Behcet's disease with mostly active uveitis did not meet its primary
endpoint. Study CAIN457C2302 was terminated to avoid continuing patients on a study with a low probability of success. Since patients did not reach the endpoint of analysis there can be no meaningful interpretation of data and data will be not provided. | |||
| NCT00362245 Details | 2015-11-03 Interventional | 4 | 0 | Amikacin Meningitis Meningitis, Bac… Gram Negative M… Post Traumatic … | lack of participants - | |||
| NCT01245543 Details | 2015-11-01 Interventional | 1 | 0 | Docetaxel Neoplasms Solid Tumors | Clinical investigations have been discontinued and transfer to BMS 3/24/2015 - | |||
| NCT00968617 Details | 2015-11-01 Interventional | 2 | 7 | Darbepoetin alf… Anemia Kidney Diseases Renal Insuffici… Chronic Kidney … | - Cohort 1 (MK2578 1.0 mcg/kg) was the only cohort initiated because the study was prematurely terminated by the sponsor. 7 participants received at least 1 dose of MK2578 & 2 participants received all 3 doses. Data presented are for Cohort 1. | |||
| NCT00924781 Details | 2015-11-01 Interventional | 2 | 39 | Epoetin Alfa Anemia Kidney Diseases Renal Insuffici… Chronic Kidney … | - Cohort 3 (MK2578 1mcg/200U) was not initiated because the study was prematurely terminated by the sponsor. All randomized participants received at least one dose of study medication. Data presented are for Cohort 1 and Cohort 2, where applicable. | |||
| NCT00692614 Details | 2015-11-01 Interventional | 2 | 2 | Triamcinolone Triamcinolone A… Triamcinolone d… Triamcinolone h… Edema Macular Edema | - - | |||
| NCT00479089 Details | 2015-11-01 Interventional | 2 | 50 | Dexamethasone Docetaxel Gefitinib Urinary Bladder… Bladder Cancer | Study halted due to drug sponsor decision to not continue. Early termination leading to small numbers of subjects analyzed. | |||
| NCT01381666 Details | 2015-10-29 Interventional | 2 | 22 | Pharmaceutical … Lung Diseases Lung Diseases, … Interstitial Lu… | - - | |||
| NCT00418470 Details | 2015-10-29 Interventional | 4 | - | Anti-Bacterial … Antibiotics, An… Cystic Fibrosis Fibrosis Phlebitis | impossibility to find volunteers - | |||
| NCT01910441 Details | 2015-10-28 Interventional | 4 | 95 | Glimepiride Metformin Vildagliptin Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes… | The study was terminated due to the unavailability of Continuous Glucose Monitoring sensors
(CGMS) which were required to assess the primary end-point. - | |||
| NCT01273181 Details | 2015-10-28 Interventional | 1/2 | 9 | Aldesleukin Cyclophosphamid… Fludarabine Kidney Neoplasm… Melanoma Neoplasm Metast… Neoplasms Neoplasms, Seco… Metastatic Canc… Metastatic Mela… Metastatic Rena… | - - | |||
| NCT00924287 NCT00805987 Details | 2015-10-28 Interventional | 1/2 | 1 | Aldesleukin Cyclophosphamid… Fludarabine Interleukin-2 Mesna Neoplasm Metast… Neoplasms Neoplasms, Seco… Metastatic Canc… | This study was terminated after the first patient treated on study died as a result of the
treatment. This study was terminated after the first patient on study died as a result of the treatment. | |||
| NCT00671112 Details | 2015-10-28 Interventional | 1 | 30 | Bortezomib Everolimus Leukemia Lymphoma 714leukemia | Treatment ineffective - | |||
| NCT00372996 2006-005573-21 Details | 2015-10-28 Interventional | 2 | 219 | Exemestane Fulvestrant Breast Neoplasm… | This study was closed to enrollment as of 13 May 2011 due to business reasons. Premature
closure was not prompted by any safety or efficacy concerns. - | |||
| NCT00282399 Details | 2015-10-28 Interventional | 1 | 41 | Decitabine Myelodysplastic… Preleukemia Syndrome Myelodysplastic… | - - | |||
| NCT00670150 Details | 2015-10-27 Interventional | 2 | 0 | Arsenic Trioxid… Leukemia Leukemia, Promy… Acute Promyeloc… | sponsor withdrew support - |